Concepts (247)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vagus Nerve Stimulation | 17 | 2022 | 27 | 3.660 |
Why?
|
| Migraine Disorders | 5 | 2022 | 48 | 1.160 |
Why?
|
| Trauma Centers | 3 | 2021 | 119 | 0.960 |
Why?
|
| Headache | 4 | 2022 | 63 | 0.860 |
Why?
|
| Wounds and Injuries | 5 | 2021 | 243 | 0.840 |
Why?
|
| Osteogenesis | 5 | 2009 | 150 | 0.780 |
Why?
|
| Electromagnetic Fields | 8 | 2009 | 22 | 0.760 |
Why?
|
| Electric Stimulation | 6 | 2016 | 137 | 0.650 |
Why?
|
| Evoked Potentials | 1 | 2018 | 35 | 0.610 |
Why?
|
| Cluster Headache | 1 | 2017 | 1 | 0.590 |
Why?
|
| Electroencephalography | 1 | 2018 | 138 | 0.580 |
Why?
|
| Cortical Spreading Depression | 3 | 2022 | 10 | 0.500 |
Why?
|
| Trigeminal Neuralgia | 1 | 2014 | 8 | 0.450 |
Why?
|
| Hyperalgesia | 1 | 2014 | 14 | 0.450 |
Why?
|
| Brain | 3 | 2019 | 1493 | 0.450 |
Why?
|
| Flail Chest | 1 | 2012 | 4 | 0.420 |
Why?
|
| Contusions | 1 | 2012 | 12 | 0.410 |
Why?
|
| Lung Injury | 1 | 2012 | 32 | 0.400 |
Why?
|
| Osteoblasts | 4 | 2009 | 205 | 0.400 |
Why?
|
| Pain Management | 2 | 2019 | 152 | 0.360 |
Why?
|
| Analgesia, Epidural | 2 | 2012 | 31 | 0.350 |
Why?
|
| Bone and Bones | 3 | 2006 | 156 | 0.340 |
Why?
|
| Spinal Fusion | 3 | 2007 | 127 | 0.340 |
Why?
|
| Spinal Diseases | 2 | 2008 | 47 | 0.320 |
Why?
|
| Rats | 9 | 2022 | 1918 | 0.310 |
Why?
|
| Electric Stimulation Therapy | 3 | 2007 | 29 | 0.310 |
Why?
|
| Fractures, Ununited | 2 | 2004 | 4 | 0.280 |
Why?
|
| Triage | 2 | 2005 | 111 | 0.260 |
Why?
|
| Bone Development | 1 | 2006 | 33 | 0.260 |
Why?
|
| Animals | 20 | 2022 | 19767 | 0.260 |
Why?
|
| Thoracic Injuries | 1 | 2005 | 47 | 0.250 |
Why?
|
| Trauma Severity Indices | 2 | 2005 | 38 | 0.240 |
Why?
|
| Nicotine | 1 | 2006 | 111 | 0.240 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2005 | 103 | 0.230 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2020 | 571 | 0.230 |
Why?
|
| Brain Ischemia | 2 | 2020 | 402 | 0.230 |
Why?
|
| Growth Substances | 1 | 2004 | 35 | 0.230 |
Why?
|
| Male | 15 | 2021 | 27970 | 0.220 |
Why?
|
| Treatment Outcome | 6 | 2019 | 5262 | 0.200 |
Why?
|
| Humans | 24 | 2021 | 60138 | 0.200 |
Why?
|
| Wound Healing | 4 | 2008 | 177 | 0.190 |
Why?
|
| Communicable Disease Control | 1 | 2021 | 38 | 0.180 |
Why?
|
| Infarction, Middle Cerebral Artery | 2 | 2020 | 72 | 0.180 |
Why?
|
| New England | 1 | 2021 | 268 | 0.180 |
Why?
|
| Infarction | 1 | 2020 | 20 | 0.180 |
Why?
|
| Vagus Nerve | 3 | 2020 | 22 | 0.170 |
Why?
|
| Pain Measurement | 2 | 2015 | 337 | 0.170 |
Why?
|
| Adult | 8 | 2021 | 15984 | 0.170 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2019 | 18 | 0.160 |
Why?
|
| Galvanic Skin Response | 1 | 2019 | 23 | 0.160 |
Why?
|
| Sjogren's Syndrome | 1 | 2018 | 26 | 0.150 |
Why?
|
| Hot Temperature | 1 | 2019 | 127 | 0.150 |
Why?
|
| Fatigue | 1 | 2018 | 104 | 0.150 |
Why?
|
| Dura Mater | 2 | 2017 | 35 | 0.150 |
Why?
|
| Gait | 1 | 2019 | 117 | 0.150 |
Why?
|
| Immunity, Cellular | 1 | 2018 | 176 | 0.150 |
Why?
|
| Parkinson Disease | 1 | 2019 | 118 | 0.140 |
Why?
|
| Blood-Brain Barrier | 1 | 2018 | 81 | 0.140 |
Why?
|
| Sensitivity and Specificity | 3 | 2006 | 1100 | 0.140 |
Why?
|
| Female | 11 | 2021 | 31249 | 0.140 |
Why?
|
| Trigeminal Nuclei | 1 | 2017 | 2 | 0.140 |
Why?
|
| Models, Neurological | 1 | 2017 | 81 | 0.140 |
Why?
|
| Bone Transplantation | 3 | 2007 | 28 | 0.140 |
Why?
|
| Pandemics | 1 | 2021 | 629 | 0.130 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2008 | 17 | 0.130 |
Why?
|
| Disease Models, Animal | 5 | 2020 | 2087 | 0.130 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2015 | 5 | 0.130 |
Why?
|
| Prostaglandins | 2 | 2014 | 18 | 0.130 |
Why?
|
| Pain | 1 | 2019 | 406 | 0.130 |
Why?
|
| Emergency Service, Hospital | 1 | 2004 | 1039 | 0.130 |
Why?
|
| Neovascularization, Physiologic | 2 | 2008 | 102 | 0.120 |
Why?
|
| Computer Simulation | 1 | 2017 | 458 | 0.120 |
Why?
|
| Down-Regulation | 1 | 2016 | 306 | 0.120 |
Why?
|
| Sleep Wake Disorders | 1 | 2015 | 69 | 0.120 |
Why?
|
| Microdialysis | 1 | 2014 | 6 | 0.110 |
Why?
|
| Nitroglycerin | 1 | 2014 | 12 | 0.110 |
Why?
|
| Retrospective Studies | 3 | 2021 | 6136 | 0.110 |
Why?
|
| Young Adult | 3 | 2019 | 4396 | 0.110 |
Why?
|
| Blood Pressure | 4 | 2020 | 522 | 0.110 |
Why?
|
| Fracture Healing | 2 | 2004 | 26 | 0.110 |
Why?
|
| Glutamic Acid | 1 | 2014 | 99 | 0.110 |
Why?
|
| Middle Aged | 7 | 2019 | 16534 | 0.110 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2014 | 79 | 0.110 |
Why?
|
| Skin | 1 | 2016 | 356 | 0.100 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2012 | 29 | 0.100 |
Why?
|
| Analgesia | 1 | 2012 | 33 | 0.100 |
Why?
|
| Bronchoconstriction | 1 | 2012 | 14 | 0.100 |
Why?
|
| Catecholamines | 1 | 2012 | 31 | 0.100 |
Why?
|
| Cytokines | 1 | 2016 | 911 | 0.100 |
Why?
|
| Cells, Cultured | 3 | 2009 | 2101 | 0.100 |
Why?
|
| Random Allocation | 2 | 2017 | 197 | 0.100 |
Why?
|
| Rabbits | 3 | 2007 | 331 | 0.090 |
Why?
|
| Neurons | 1 | 2017 | 862 | 0.090 |
Why?
|
| Stroke | 1 | 2020 | 1144 | 0.090 |
Why?
|
| Respiratory Insufficiency | 1 | 2012 | 155 | 0.090 |
Why?
|
| Biophysics | 2 | 2012 | 43 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2009 | 200 | 0.080 |
Why?
|
| Respiration, Artificial | 1 | 2012 | 296 | 0.080 |
Why?
|
| Osteoprotegerin | 1 | 2009 | 7 | 0.080 |
Why?
|
| Calcium Phosphates | 1 | 2009 | 8 | 0.080 |
Why?
|
| RANK Ligand | 1 | 2009 | 24 | 0.080 |
Why?
|
| Caproates | 1 | 2008 | 1 | 0.080 |
Why?
|
| Lactones | 1 | 2008 | 25 | 0.080 |
Why?
|
| Laminectomy | 1 | 2008 | 20 | 0.080 |
Why?
|
| Polyesters | 1 | 2008 | 47 | 0.070 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 171 | 0.070 |
Why?
|
| Risk Assessment | 2 | 2005 | 1937 | 0.070 |
Why?
|
| Growth Plate | 1 | 2007 | 14 | 0.070 |
Why?
|
| Femur | 1 | 2007 | 54 | 0.070 |
Why?
|
| Biocompatible Materials | 1 | 2008 | 142 | 0.070 |
Why?
|
| Heart Rate | 2 | 2020 | 308 | 0.070 |
Why?
|
| Surgical Flaps | 1 | 2008 | 112 | 0.070 |
Why?
|
| Electrodes, Implanted | 2 | 2017 | 38 | 0.070 |
Why?
|
| Bone Matrix | 1 | 2006 | 4 | 0.070 |
Why?
|
| Radiography | 2 | 2007 | 514 | 0.060 |
Why?
|
| Orthopedics | 1 | 2006 | 29 | 0.060 |
Why?
|
| Stress, Mechanical | 1 | 2006 | 111 | 0.060 |
Why?
|
| Morphogenesis | 1 | 2006 | 113 | 0.060 |
Why?
|
| Range of Motion, Articular | 1 | 2006 | 87 | 0.060 |
Why?
|
| Probability | 1 | 2006 | 173 | 0.060 |
Why?
|
| Transplantation, Homologous | 1 | 2006 | 236 | 0.060 |
Why?
|
| Pregnancy Complications | 1 | 2010 | 392 | 0.060 |
Why?
|
| Catheters, Indwelling | 1 | 2005 | 69 | 0.060 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2005 | 33 | 0.060 |
Why?
|
| Reference Values | 1 | 2006 | 322 | 0.060 |
Why?
|
| Nerve Block | 1 | 2005 | 42 | 0.060 |
Why?
|
| Combined Modality Therapy | 1 | 2006 | 361 | 0.060 |
Why?
|
| Biomechanical Phenomena | 1 | 2006 | 247 | 0.060 |
Why?
|
| Fractures, Bone | 1 | 2006 | 150 | 0.060 |
Why?
|
| Transportation of Patients | 1 | 2005 | 43 | 0.060 |
Why?
|
| United States | 1 | 2017 | 7622 | 0.060 |
Why?
|
| Progressive Patient Care | 1 | 2004 | 3 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2019 | 930 | 0.060 |
Why?
|
| Injury Severity Score | 1 | 2004 | 102 | 0.050 |
Why?
|
| Gene Expression | 1 | 2007 | 807 | 0.050 |
Why?
|
| Registries | 2 | 2005 | 809 | 0.050 |
Why?
|
| Emergencies | 1 | 2004 | 114 | 0.050 |
Why?
|
| Safety | 1 | 2004 | 141 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 161 | 0.050 |
Why?
|
| In Vitro Techniques | 1 | 2004 | 472 | 0.050 |
Why?
|
| Endothelial Cells | 1 | 2004 | 177 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2004 | 370 | 0.050 |
Why?
|
| Neutrophils | 1 | 2005 | 351 | 0.050 |
Why?
|
| Comorbidity | 1 | 2005 | 1098 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2008 | 1172 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 1035 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2005 | 508 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2004 | 685 | 0.040 |
Why?
|
| Reperfusion Injury | 1 | 2020 | 51 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2004 | 1315 | 0.040 |
Why?
|
| Adolescent | 3 | 2019 | 5958 | 0.040 |
Why?
|
| Pain Perception | 1 | 2019 | 7 | 0.040 |
Why?
|
| Infant | 1 | 2004 | 1531 | 0.040 |
Why?
|
| Neural Pathways | 1 | 2019 | 97 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2004 | 1850 | 0.040 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2009 | 54 | 0.040 |
Why?
|
| Time Factors | 3 | 2016 | 3618 | 0.040 |
Why?
|
| Aged | 3 | 2019 | 13584 | 0.040 |
Why?
|
| Finite Element Analysis | 1 | 2017 | 14 | 0.040 |
Why?
|
| Brain Mapping | 1 | 2019 | 228 | 0.040 |
Why?
|
| Massachusetts | 1 | 2004 | 2117 | 0.040 |
Why?
|
| Lower Extremity | 1 | 2019 | 146 | 0.040 |
Why?
|
| Nociceptive Pain | 1 | 2017 | 1 | 0.040 |
Why?
|
| Killer Cells, Natural | 1 | 2018 | 215 | 0.040 |
Why?
|
| Radiation Dosage | 2 | 2009 | 130 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2005 | 2891 | 0.030 |
Why?
|
| Culture Media, Conditioned | 2 | 2009 | 51 | 0.030 |
Why?
|
| Action Potentials | 1 | 2017 | 103 | 0.030 |
Why?
|
| Functional Laterality | 1 | 2017 | 133 | 0.030 |
Why?
|
| Blood Cells | 1 | 2016 | 17 | 0.030 |
Why?
|
| Blood Culture | 1 | 2016 | 12 | 0.030 |
Why?
|
| Solitary Nucleus | 1 | 2015 | 7 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2016 | 71 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2015 | 53 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2016 | 209 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2019 | 2049 | 0.030 |
Why?
|
| Models, Animal | 1 | 2016 | 222 | 0.030 |
Why?
|
| Cervical Vertebrae | 1 | 2015 | 102 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2016 | 680 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 807 | 0.030 |
Why?
|
| Child | 1 | 2004 | 4335 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 969 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 645 | 0.030 |
Why?
|
| Guanethidine | 1 | 2012 | 3 | 0.030 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2012 | 11 | 0.030 |
Why?
|
| Propranolol | 1 | 2012 | 22 | 0.030 |
Why?
|
| Histamine | 1 | 2012 | 27 | 0.030 |
Why?
|
| Ligation | 1 | 2012 | 35 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2015 | 745 | 0.020 |
Why?
|
| Adrenergic Agents | 1 | 2012 | 16 | 0.020 |
Why?
|
| Guinea Pigs | 1 | 2012 | 103 | 0.020 |
Why?
|
| Epinephrine | 1 | 2012 | 42 | 0.020 |
Why?
|
| Acetylcholine | 1 | 2012 | 44 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2012 | 61 | 0.020 |
Why?
|
| Norepinephrine | 1 | 2012 | 99 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 449 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 346 | 0.020 |
Why?
|
| Gestational Age | 1 | 2010 | 184 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2015 | 2479 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 2009 | 14 | 0.020 |
Why?
|
| Cesarean Section | 1 | 2010 | 97 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 5198 | 0.020 |
Why?
|
| Tissue Adhesions | 1 | 2008 | 20 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2015 | 3131 | 0.020 |
Why?
|
| Sheep | 1 | 2008 | 168 | 0.020 |
Why?
|
| Fibrosis | 1 | 2008 | 152 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2008 | 182 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2008 | 102 | 0.020 |
Why?
|
| Necrosis | 1 | 2008 | 140 | 0.020 |
Why?
|
| Computer Systems | 1 | 2007 | 15 | 0.020 |
Why?
|
| Receptors, Growth Factor | 1 | 2007 | 20 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2007 | 118 | 0.020 |
Why?
|
| Spine | 1 | 2007 | 48 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2007 | 286 | 0.020 |
Why?
|
| Ischemia | 1 | 2008 | 195 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2007 | 155 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 525 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2007 | 531 | 0.020 |
Why?
|
| Oscillometry | 1 | 2005 | 12 | 0.020 |
Why?
|
| NADP | 1 | 2005 | 24 | 0.020 |
Why?
|
| Cell Size | 1 | 2005 | 41 | 0.010 |
Why?
|
| New York | 1 | 2005 | 137 | 0.010 |
Why?
|
| Magnetics | 1 | 2005 | 53 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2009 | 943 | 0.010 |
Why?
|
| Paracrine Communication | 1 | 2004 | 15 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2004 | 33 | 0.010 |
Why?
|
| Cell Line | 1 | 2009 | 2017 | 0.010 |
Why?
|
| Laminin | 1 | 2004 | 76 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2005 | 144 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2005 | 305 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2004 | 138 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2004 | 136 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2005 | 202 | 0.010 |
Why?
|
| Collagen | 1 | 2004 | 119 | 0.010 |
Why?
|
| Ultrasonic Therapy | 1 | 2003 | 9 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 400 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 443 | 0.010 |
Why?
|
| Pregnancy | 1 | 2010 | 2367 | 0.010 |
Why?
|
| Mice | 2 | 2008 | 10342 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2005 | 492 | 0.010 |
Why?
|
| Cell Movement | 1 | 2004 | 425 | 0.010 |
Why?
|
| DNA Replication | 1 | 2004 | 229 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2009 | 1539 | 0.010 |
Why?
|
| Calcium | 1 | 2005 | 558 | 0.010 |
Why?
|
| Logistic Models | 1 | 2005 | 1259 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2007 | 1470 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2004 | 1227 | 0.010 |
Why?
|